Shared Decision-Making in Growth Hormone Therapy—Implications for Patient Care
Several studies have shown that adherence to growth hormone therapy (GHT) is not optimal. There are several reasons why patients may not fully adhere to their treatment regimen and this may have implications on treatment success, patient outcomes and healthcare spending and resourcing. A change in h...
Main Authors: | Carlo L. Acerini, David Segal, Sherwin Criseno, Kei Takasawa, Navid Nedjatian, Sebastian Röhrich, Mohamad Maghnie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2018.00688/full |
Similar Items
-
Optimizing Patient Management and Adherence for Children Receiving Growth Hormone
by: Carlo L. Acerini, et al.
Published: (2017-11-01) -
Rationale and proposed framework for shared decision making in cardio-oncology
by: Sarah C. Hull, et al.
Published: (2021-08-01) -
Leveraging the Power of Shared Governance
by: Cohen, Cynthia S.
Published: (2015) -
Leveraging the Power of Shared Governance
by: Cohen, Cynthia S.
Published: (2015) -
Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making
by: Jennifer Jo Thompson, et al.
Published: (2017-10-01)